You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • FRI0186 Impact of Concomitant Methotrexate Dose on the Efficacy and Safety of Sarilumab for Treatment of Moderate-to-Severe Rheumatoid Arthritis: The Mobility Study

Citation Tools

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - other biologic treatment
FRI0186 Impact of Concomitant Methotrexate Dose on the Efficacy and Safety of Sarilumab for Treatment of Moderate-to-Severe Rheumatoid Arthritis: The Mobility Study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Huizinga T, Yazici Y, Thompson D, et al
FRI0186 Impact of Concomitant Methotrexate Dose on the Efficacy and Safety of Sarilumab for Treatment of Moderate-to-Severe Rheumatoid Arthritis: The Mobility Study
Annals of the Rheumatic Diseases 2015;74:491-492.